ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 25 filers reported holding ARCA BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 8.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $162,783 | +115.2% | 42,502 | 0.0% | 0.00% | – |
| Q1 2024 | $75,654 | +4.7% | 42,502 | -0.0% | 0.00% | – |
| Q4 2023 | $72,274 | -15.4% | 42,514 | 0.0% | 0.00% | – |
| Q3 2023 | $85,453 | -1.0% | 42,514 | +0.0% | 0.00% | – |
| Q2 2023 | $86,279 | +2.0% | 42,502 | 0.0% | 0.00% | – |
| Q1 2023 | $84,579 | +84479.0% | 42,502 | 0.0% | 0.00% | – |
| Q4 2022 | $100 | -99.9% | 42,502 | +0.0% | 0.00% | – |
| Q3 2022 | $88,000 | -17.0% | 42,498 | 0.0% | 0.00% | – |
| Q2 2022 | $106,000 | +8.2% | 42,498 | 0.0% | 0.00% | – |
| Q1 2022 | $98,000 | +7.7% | 42,498 | 0.0% | 0.00% | – |
| Q4 2021 | $91,000 | – | 42,498 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 500,000 | $1,030,000 | 0.23% |
| SG3 Management, LLC | 200,000 | $412,000 | 0.03% |
| Marquette Asset Management, LLC | 17,318 | $36,000 | 0.01% |
| SG3 Management, LLC | 75,412 | $155,674 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,948 | $97,000 | 0.00% |
| Tekla Capital Management LLC | 32,461 | $67,000 | 0.00% |
| Virtu Financial LLC | 14,221 | $29,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 144,284 | $297,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 96 | $0 | 0.00% |
| NORTHERN TRUST CORP | 17,517 | $36,000 | 0.00% |